Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Francisco Alves; Inês F Antunes; Emiliano Cazzola; Frederik Cleeren; Bart Cornelissen; Antonia Denkova; Jonathan Engle; Alain Faivre-Chauvet; Nic Gillings; Jeroen J M A Hendrikx; Amir R Jalilian; Nicholas P van der Meulen; Renata Mikolajczak; Oliver C Neels; Maroor R A Pillai; Raymond Reilly; Sietske Rubow; Yann Seimbille; Sarah Spreckelmeyer; Wiktor Szymanski; Carlotta Taddei

doi:10.1186/s41181-021-00146-9

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

EJNMMI Radiopharm Chem. 2021 Sep 8;6(1):31. doi: 10.1186/s41181-021-00146-9.

Authors

Francisco Alves¹, Inês F Antunes², Emiliano Cazzola³, Frederik Cleeren⁴, Bart Cornelissen², Antonia Denkova⁵, Jonathan Engle⁶, Alain Faivre-Chauvet⁷, Nic Gillings⁸, Jeroen J M A Hendrikx⁹, Amir R Jalilian¹⁰, Nicholas P van der Meulen¹¹, Renata Mikolajczak¹², Oliver C Neels¹³, Maroor R A Pillai¹⁴, Raymond Reilly¹⁵, Sietske Rubow¹⁶, Yann Seimbille¹⁷, Sarah Spreckelmeyer¹⁸, Wiktor Szymanski¹⁹, Carlotta Taddei²⁰

Affiliations

¹ University of Coimbra, Coimbra, Portugal.
² UMCG, Groningen, The Netherlands.
³ Sacro Cuore Hospital, Verona, Italy.
⁴ Katholieke Universiteit, Leuven, Belgium.
⁵ Technische Universiteit, Delft, The Netherlands.
⁶ University of Wisconsin, Madison, WI, USA.
⁷ Inserm, CNRS, Nantes, France.
⁸ Rigshospitalet, Copenhagen, Denmark.
⁹ NKI, Amsterdam, The Netherlands.
¹⁰ IAEA, Vienna, Austria.
¹¹ PSI, Villigen, Switzerland.
¹² Polatom, Otwock, Poland.
¹³ Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. o.neels@hzdr.de.
¹⁴ Molecular Group of Companies, Cochin, Kerala, India.
¹⁵ University of Toronto, Toronto, Canada.
¹⁶ Stellenbosch University, Stellenbosch, South Africa.
¹⁷ Erasmus MC, Rotterdam, The Netherlands.
¹⁸ Charite, Berlin, Germany.
¹⁹ University of Groningen, Groningen, The Netherlands.
²⁰ NIH, Bethesda, USA.

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included.

Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Keywords: Highlight selection; Radiochemistry; Radiopharmacy.

Publication types

Review

Abstract

Publication types

Grants and funding